Category: Antisense & RNAi Technology
Global Antisense & RNAi Technology
-
The 2023-2028 World Outlook for Antisense and RNAi Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for RNAi Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for RNAi Drug Deliveries
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for RNAi Therapies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026
... therapeutics market by value, by molecule type, by application, by region, etc. The report provides a regional analysis of the RNAi therapeutics market, including North America (The US, Canada, and Mexico), Europe, Asia Pacific, Middle ... Read More
-
Global Oligonucleotide Synthesis Market Size study, By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, Equipment), By Application (Research Applications {PCR, Sequencing, Other Research Applications}, Diagnostic Applications), By Type (Antisense Oligonucleotide-Based Therapies, Rnai Oligonucleotide-Based Therapies, Cpg Oligonucleotide-Based Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028
... Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028Global Oligonucleotide Synthesis Market is valued approximately ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2022
... assess the global antisense & RNAi therapeutics market. This report focuses on antisense & RNAi therapeutics market which is experiencing strong growth. The report gives a guide to the antisense & RNAi therapeutics market which ... Read More
-
Global RNA Based Therapeutic Market By Type (RNA Antisense and RNA Interference (RNAi)), By Application (Genetic disorders and Auto immune disorders), By End User (Research Institutes and Hospitals & Clinics), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
... Report and Forecast, 2021 - 2027 The Global RNA Based Therapeutic Market size is expected to reach $11.4 billion by 2027, rising at a market growth of 15.1 % CAGR during the forecast period. RNA-based ... Read More
-
Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, Antisense, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow ... Read More
Research Assistance
